Latest Product News
BrainLAB Announces Availability of iPlan® RT Treatment Planning Platform
iPlan RT gives clinicians the flexibility to combine complete diagnostic information with broader treatment options.
Myriad Introduces Enhanced BRACAnalysis® Test for Breast Cancer Patients
BART™ technology detects rare DNA rearrangements in BRCA1 and BRCA2 genes.
DxS Launch Latest Oncogene Mutation Test kit
The kit improves the detection of T790M mutations on the EGFR gene.
Nanogen Releases Real-Time PCR Reagents
Nanogen includes MGB Alert™ real-time PCR reagents to its product portfolio.
Genoptix Announces FDA Cleared Test to Identify Circulating Tumor Cells
Test helps physicians and patients fight metastatic breast cancer sooner.
bmd Enters two Diagnostic Markets with the Launch of FIDIS™ Kits
Epstein Barr and atherosclerosis tests strengthen bmd position in automated Multiplex arena.
Cepheid Launches CE Mark Certification Smart CMV™ In Vitro Diagnostic Test for SmartCycler® Platform
The test delivers diagnostics for improved management of immunocompromised patients.
Siemens Highlights Molecular Imaging Solutions for Cardiology, Oncology and Neurology
Siemens' molecular imaging technologies are enabling clinicians and researchers to effectively treat within and further explore these areas.
Tools Improve Treatment Management of AML Patients
Genzyme announces the availability of two new molecular tests for acute myelogenous leukemia.
Xenomics to Present DNA Medical Diagnostic Platform at Rodman & Renshaw Healthcare Conference
CEO Dr. David Tomei to discuss research data and potential product applications of non-Invasive Tr-DNA medical testing technology.